Found: 11
Select item for more details and to access through your institution.
Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab.
- Published in:
- European Journal of Health Economics, 2012, v. 13, n. 5, p. 589, doi. 10.1007/s10198-011-0323-1
- By:
- Publication type:
- Article
“Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK”: How important is quality of life?
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 188, doi. 10.1007/s10198-004-0226-5
- By:
- Publication type:
- Article
Commentary on Coyle et al., "The assessment of the economic return from controlled clinical trials".
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 3, p. 239, doi. 10.1007/s10198-003-0191-4
- By:
- Publication type:
- Article
National spending and uptake of mobile radiology services in aged care facilities: an opportunity to improve access remains.
- Published in:
- Internal Medicine Journal, 2021, v. 51, n. 12, p. 2157, doi. 10.1111/imj.15611
- By:
- Publication type:
- Article
Cost-Effectiveness of Letrozole in the Extended Adjuvant Treatment of Women with Early Breast Cancer.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 101, n. 1, p. 37, doi. 10.1007/s10549-006-9262-4
- By:
- Publication type:
- Article
Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer, Based on Survival Data and Future Prices for Generic Drugs in the Context of the German Health Care System.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
The Value of Value of Information: Best Informing Research Design and Prioritization Using Current Methods.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 9, p. 699, doi. 10.2165/11537370-000000000-00000
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Adjuvant Therapy for Operable Breast Cancer from a Chinese Perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus Cyclophosphamide.
- Published in:
- PharmacoEconomics, 2009, v. 27, n. 10, p. 873, doi. 10.2165/11314750-000000000-00000
- By:
- Publication type:
- Article
A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy: for advanced breast cancer in postmenopausal patients.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Piloting home infusions of Tysabri (natalizumab): a randomised crossover trial.
- Published in:
- International Journal of Integrated Care (IJIC), 2019, v. 19, n. S1, p. 1, doi. 10.5334/ijic.s3617
- By:
- Publication type:
- Article
An equity-effectiveness framework linking health programs and healthy life expectancy.
- Published in:
- Australian Journal of Primary Health, 2011, v. 17, n. 4, p. 309, doi. 10.1071/PY11034
- By:
- Publication type:
- Article